Every established consumer brand was, at some point, an unknown quantity trying to convince a skeptical public to hand over money for something unfamiliar. The path from “who are these people” to “of course I trust that brand” is rarely accidental. It tends to follow a fairly consistent pattern across industries, and studying that pattern reveals a lot about how quickly a new company can build genuine credibility versus how much simply cannot be rushed, regardless of marketing budget.
The Old Playbook Doesn’t Work Anymore
For much of the twentieth century, brand trust was built primarily through advertising reach and repetition. Show up often enough, in enough places, with a consistent message, and consumers eventually internalized a brand as familiar and therefore safe. That playbook still works to a degree, but it has lost much of its power in categories where consumers have learned to be skeptical of polish, precisely because polish is now cheap and easy to produce. Anyone can hire a design agency and run a slick ad campaign. Fewer companies can produce actual, verifiable proof of what they claim about their own products.
This has created an opening for a different kind of trust-building, one based on documentation and transparency rather than repetition and polish, and it has proven especially important in newer or less-regulated product categories where consumers cannot simply rely on decades of government oversight to separate legitimate businesses from opportunistic ones.
Case Study: The Botanical Products Category
One useful place to watch this play out is the growing botanical products industry, a category encompassing herbal teas, specialty powders, and other plant-derived consumer goods, including kratom, an herbal product that has grown considerably in popularity while regulatory frameworks around it remain a patchwork from state to state. Because this category lacks the kind of uniform federal oversight that governs, say, prescription pharmaceuticals, companies operating in it have had to build trust almost entirely through voluntary transparency rather than regulatory assurance.
The companies that have done this most effectively share a few common traits: they publish third-party lab results tied to specific production batches rather than making general quality claims, they disclose sourcing information in some detail rather than treating it as proprietary, and they tend to control more of their own supply chain, from raw material to finished product, which allows them to vouch for quality at every stage rather than depending on the word of outside vendors they do not directly oversee.
Why Vertical Integration Keeps Coming Up
Vertical integration, meaning a company that handles sourcing, processing, and testing internally rather than piecing together a supply chain from multiple outside vendors, keeps surfacing as a recurring theme among the more credible players in newer, less-regulated consumer categories. The logic is fairly intuitive: every hand-off to an outside vendor introduces a point where quality control could slip and where a company’s ability to vouch for its own product weakens slightly. A vertically integrated manufacturer has fewer of those hand-offs and, as a result, an easier time producing detailed, batch-specific documentation.
Companies like Kingdom Kratom illustrate this dynamic within the botanical products space specifically, having built operations spanning sourcing, processing, and testing rather than relying on a network of importers and repackagers. That structural choice gives a manufacturer more direct control over the documentation it can offer retail partners and consumers, which in a category still working out its regulatory footing, has become a genuine competitive advantage rather than just an operational preference.
The Regulatory Catch-Up Is Coming
History suggests that categories operating in a regulatory gray zone rarely stay there indefinitely. Eventually, enough consumer complaints, media attention, or industry lobbying pushes state or federal regulators to establish clearer rules, and when that happens, companies that already built robust internal testing and documentation practices tend to adapt with minimal disruption, while companies that treated transparency as optional often scramble to meet new requirements they should have anticipated years earlier.
Several states have already moved in this direction with botanical products specifically, passing versions of consumer protection acts that establish baseline testing, labeling, and age-verification standards for retailers. Industry watchers expect more states to follow a similar path in the coming years, gradually converting today’s voluntary transparency practices into tomorrow’s legal requirements.
What This Means for the Next Generation of Consumer Brands
For entrepreneurs and executives building brands in any newer, less-regulated product category, the lesson from watching categories like botanical products mature is fairly clear: transparency built early, before it is legally required, pays dividends twice. It builds consumer trust in the near term, when marketing polish alone would otherwise struggle to differentiate a new brand from its competitors, and it reduces regulatory disruption in the long term, when rules eventually catch up to a fast-growing category and companies without existing documentation infrastructure find themselves scrambling.
That two-part payoff explains why so many of the more durable brands emerging in loosely regulated categories today look less like traditional advertising-driven consumer brands and more like companies quietly building the operational and documentation infrastructure of a much more heavily regulated industry, years before any regulator actually requires them to.
The Consumers Doing the Vetting Themselves
None of this transparency infrastructure would matter much if consumers were not actually using it, and the evidence suggests they increasingly are. Surveys of shoppers in emerging wellness and specialty product categories consistently show a growing willingness to research a brand before purchasing, checking for lab documentation, reading independent reviews that reference testing rather than just satisfaction, and comparing sourcing claims across competing brands before making a decision. This is a meaningfully different consumer than the one advertisers spent most of the last century optimizing for, one who treats a lack of documentation as a red flag rather than simply an absence of information.
That behavioral shift is arguably the real engine behind the trust-building patterns described here. Companies did not start publishing detailed lab results purely out of civic-minded transparency; they did it because a critical mass of consumers started demanding it, rewarding the brands that provided it with loyalty and market share, and gradually punishing the brands that did not. For any executive building a brand in a newer or loosely regulated category today, that consumer behavior is worth taking seriously as a market signal in its own right, not just a compliance consideration to address later once regulation forces the issue.
